Результаты исследований: Научные публикации в периодических изданиях › статья
Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. / Vinceti, M.; Solovyev, N.; Mandrioli, J.; Crespi, C.M.; Bonvicini, F.; Arcolin, E.; Georgoulopoulou, E.; Michalke, B.
в: NeuroToxicology, Том 38, 2013, стр. 25-32.Результаты исследований: Научные публикации в периодических изданиях › статья
}
TY - JOUR
T1 - Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite
AU - Vinceti, M.
AU - Solovyev, N.
AU - Mandrioli, J.
AU - Crespi, C.M.
AU - Bonvicini, F.
AU - Arcolin, E.
AU - Georgoulopoulou, E.
AU - Michalke, B.
PY - 2013
Y1 - 2013
N2 - Exposure to selenium, and particularly to its inorganic forms, has been hypothesized as a risk factor for amyotrophic lateral sclerosis (ALS), a fast progressing motor neuron disease with poorly understood etiology. However, no information is known about levels of inorganic and some organic selenium species in the central nervous system of ALS patients, and recent observations suggest that peripheral biomarkers of exposure are unable to predict these levels for several Se species including the inorganic forms. Using a hospital-referred case–control series and advanced selenium speciation methods, we compared the chemical species of selenium in cerebrospinal fluid from 38 ALS patients to those of 38 reference neurological patients matched on age and gender. We found that higher concentrations of inorganic selenium in the form of selenite and of human serum albumin-bound selenium were associated with increased ALS risk (relative risks 3.9 (95% confidence interval 1.2–11.0) and 1.7 (1.0–2.9) for 0.1 μg/L increas
AB - Exposure to selenium, and particularly to its inorganic forms, has been hypothesized as a risk factor for amyotrophic lateral sclerosis (ALS), a fast progressing motor neuron disease with poorly understood etiology. However, no information is known about levels of inorganic and some organic selenium species in the central nervous system of ALS patients, and recent observations suggest that peripheral biomarkers of exposure are unable to predict these levels for several Se species including the inorganic forms. Using a hospital-referred case–control series and advanced selenium speciation methods, we compared the chemical species of selenium in cerebrospinal fluid from 38 ALS patients to those of 38 reference neurological patients matched on age and gender. We found that higher concentrations of inorganic selenium in the form of selenite and of human serum albumin-bound selenium were associated with increased ALS risk (relative risks 3.9 (95% confidence interval 1.2–11.0) and 1.7 (1.0–2.9) for 0.1 μg/L increas
KW - Selenium
KW - Selenite
KW - Selenoprotein-P
KW - Amyotrophic lateral sclerosis
KW - Case–control study
KW - Cerebrospinal fluid
KW - Risk
KW - Environment
KW - Speciation analysis
U2 - 10.1016/j.neuro.2013.05.016
DO - 10.1016/j.neuro.2013.05.016
M3 - Article
VL - 38
SP - 25
EP - 32
JO - NeuroToxicology
JF - NeuroToxicology
SN - 0161-813X
ER -
ID: 7376998